REGENEREX PHARMA, INC. (RGPX) › Shareholders' EquityREGENEREX PHARMA, INC. (RGPX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $15.5K2011: -$122.3K2012: -$749.7K2013: -$1.70M2014: -$795.4K2016: -$279.1K2017: -$321.1K2018: -$321.1K2019: -$369.7K2020: -$481.3K2021: -$835.0K2022: -$985.6K2023: -$1.12M2024: -$4.06M2025: -$4.16M-$4.16M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$4.16M-2.3%2024-$4.06M-261.7%2023-$1.12M-13.9%2022-$985.6K-18.0%2021-$835.0K-73.5%2020-$481.3K-30.2%2019-$369.7K-15.1%2018-$321.1K+0.0%2017-$321.1K-15.0%2016-$279.1K—2014-$795.4K+53.2%2013-$1.70M-126.8%2012-$749.7K-512.8%2011-$122.3K-889.2%2010$15.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share